CHOCO-CABANA Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04539145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT04539145
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Germany, New Zealand
- Registry status
- Unknown status
Technical summary
Registry record NCT04539145. Randomized; single masking; primary purpose treatment. Start 2020-08-04 (actual); primary completion 2022-03-27 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CHOCO-CABANA Trial
- Condition
- Atherosclerosis
- Intervention (Device)
- Chocolate PTA Balloon
- Intervention (Device)
- conventional balloon angioplasty
- Lead sponsor
- Klinikum Rosenheim
- Collaborator
- Medtronic
- Collaborator
- Herz-Zentrums Bad Krozingen
- Collaborator
- University Hospital Tuebingen
- Collaborator
- Klinikum Karlsbad-Langensteinbach
- Collaborator
- Elblandklinikum Radebeul Interdisziplinäres Gefäßzentrum Radebeul / Riesa
- Collaborator
- Universitäts-Frauenklinik Graz
- Collaborator
- Hanusch-Krankenhaus Kardiovaskuläres Zentrum
- Collaborator
- Auckland City Hospital
- Collaborator
- SCO:SSiS
- Collaborator
- coreLab Black Forest GmbH
- Collaborator
- Charite University, Berlin, Germany
Record details
- Record id
cardio:ct-nct04539145- Content hash
90720538ef73ffd65d3efe8c07a4164dba917722543b2575c96913526a43d383